BDX FY 2024 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

FY 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$20.2B+4.2% YoY

Gross Profit

$9.1B45.2% margin

Operating Income

$2.4B11.9% margin

Net Income

$1.7B8.4% margin

EPS (Diluted)

$5.86

Cash Flow

Operating Cash Flow

$3.8B

Free Cash Flow

$3.1B

Stock-Based Comp.

$247M

Balance Sheet

Total Assets

$57.3B

Total Liabilities

$31.4B

Stockholders' Equity

$25.9B

Cash & Equivalents

$1.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20.2B	$19.4B	+4.2%
Gross Profit	$9.1B	$8.2B	+11.7%
Operating Income	$2.4B	$2.1B	+13.5%
Net Income	$1.7B	$1.5B	+14.9%